These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 152621)

  • 1. Huntington's disease. Cerebrospinal fluid GABA levels in at-risk individuals.
    Manyam NV; Hare TA; Katz L; Glaeser BS
    Arch Neurol; 1978 Nov; 35(11):728-30. PubMed ID: 152621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gamma-aminobutyric acid (GABA) in cerebrospinal fluid.
    Kuroda H
    Acta Med Okayama; 1983 Jun; 37(3):167-77. PubMed ID: 6224397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human CSF GABA concentrations: revised downward for controls, but not decreased in Huntington's chorea.
    Perry TL; Hansen S; Wall RA; Gauthier SG
    J Neurochem; 1982 Mar; 38(3):766-73. PubMed ID: 6460090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levels of gamma-aminobutyric acid in cerebrospinal fluid in various neurologic disorders.
    Manyam NV; Katz L; Hare TA; Gerber JC; Grossman MH
    Arch Neurol; 1980 Jun; 37(6):352-5. PubMed ID: 6446278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Free and conjugated CSF and plasma GABA in Huntington's chorea.
    Uhlhaas S; Lange H; Wappenschmidt J; Olek K
    Acta Neurol Scand; 1986 Oct; 74(4):261-5. PubMed ID: 3028028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Further characterization of in vitro conditions appropriate for GABA determination in human CSF: impact of acid deproteinization and freeze/thaw.
    Ferraro TN; Manyam BV; Hare TA
    J Neurochem; 1983 Oct; 41(4):1057-64. PubMed ID: 6225837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebrospinal fluid GABA and homocarnosine concentrations in patients with Friedreich's ataxia, Parkinson's disease, and Huntington's chorea.
    Bonnet AM; Tell G; Schechter PJ; Grove J; Saint-Hilaire MH; De Smet Y; Agid Y
    Mov Disord; 1987; 2(2):117-23. PubMed ID: 2973560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrospinal fluid gamma-aminobutyric acid variations in neurological disorders.
    Enna SJ; Stern LZ; Wastek GJ; Yamamura HI
    Arch Neurol; 1977 Nov; 34(11):683-5. PubMed ID: 143928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of isoniazid on cerebrospinal fluid and plasma GABA levels in Huntington's disease.
    Manyam NV; Hare TA; Katz L
    Life Sci; 1980 Apr; 26(16):1303-8. PubMed ID: 6446011
    [No Abstract]   [Full Text] [Related]  

  • 10. Free and conjugated GABA in human cerebrospinal fluid: effect of degenerative neurologic diseases and isoniazid.
    Manyam BV; Tremblay RD
    Brain Res; 1984 Jul; 307(1-2):217-23. PubMed ID: 6235893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Letter: Low GABA levels in CSF in Huntington's chorea.
    Glaeser BS; Hare TA; Vogel WH; Olewiler DB; Beasley BL
    N Engl J Med; 1975 May; 292(19):1029-30. PubMed ID: 235093
    [No Abstract]   [Full Text] [Related]  

  • 12. Cerebrospinal fluid acetylcholinesterase and choline measurements in Huntington's disease.
    Manyam BV; Giacobini E; Colliver JA
    J Neurol; 1990 Aug; 237(5):281-4. PubMed ID: 2146369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GABA levels in cerebrospinal fluid of patients with Huntington's chorea: a preliminary report.
    Glaeser BS; Vogel WH; Oleweiler DB; Hare TA
    Biochem Med; 1975 Apr; 12(4):380-5. PubMed ID: 126061
    [No Abstract]   [Full Text] [Related]  

  • 14. Isoniazid-induced elevation of CSF GABA levels and effects on chorea in Huntington's disease.
    Manyam BV; Katz L; Hare TA; Kaniefski K; Tremblay RD
    Ann Neurol; 1981 Jul; 10(1):35-7. PubMed ID: 6455963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebrospinal fluid gamma-aminobutyric acid in neurologic disease.
    Achar VS; Welch KM; Chabi E; Bartosh K; Meyer JS
    Neurology; 1976 Aug; 26(8):777-80. PubMed ID: 133299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isoniazid-induced alteration of CSF neurotransmitter amino acids in Huntington's disease.
    Manyam BV; Ferraro TN; Hare TA
    Brain Res; 1987 Apr; 408(1-2):125-30. PubMed ID: 2885064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GABA in cerebrospinal fluid of children with febrile convulsions.
    Löscher W; Rating D; Siemes H
    Epilepsia; 1981 Dec; 22(6):697-702. PubMed ID: 6273149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropeptide Y (NPY) in cerebrospinal fluid from patients with Huntington's Disease: increased NPY levels and differential degradation of the NPY1-30 fragment.
    Wagner L; Björkqvist M; Lundh SH; Wolf R; Börgel A; Schlenzig D; Ludwig HH; Rahfeld JU; Leavitt B; Demuth HU; Petersén Å; von Hörsten S
    J Neurochem; 2016 Jun; 137(5):820-37. PubMed ID: 27016395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Normal hypocretin-1 (orexin-A) levels in the cerebrospinal fluid of patients with Huntington's disease.
    Meier A; Mollenhauer B; Cohrs S; Rodenbeck A; Jordan W; Meller J; Otto M
    Brain Res; 2005 Nov; 1063(2):201-3. PubMed ID: 16263095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low cerebrospinal fluid gamma-aminobutyric acid content in seizure patients.
    Wood JH; Hare TA; Glaeser BS; Ballenger JC; Post RM
    Neurology; 1979 Sep; 29(9 Pt 1):1203-8. PubMed ID: 113694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.